Redmile Group, LLC

Holdings History for FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

Symbol: FATE on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 17,941,579 shares
Security Ownership %: 15%

Shares, Excluding Options vs Price

Value, Excluding Options

Redmile Group, LLC ownership in FATE THERAPEUTICS INC Common Stock, par value $0.001 per share (FATE)

03 Jul 2025 - Redmile Group, LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 17,941,579 shares of FATE THERAPEUTICS INC Common Stock, par value $0.001 per share (FATE). This represents 15% ownership of the company. In their previous filing dated 26 Dec 2024, Redmile Group, LLC had reported owning 17,816,634 shares, indicating an increase of +0.7%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Redmile Group, LLC	15%	0%	$25,118,211	17,941,579	+124,945	+0.7%	$1.40	13D/A	02 Jul 2025	03 Jul 2025, 16:01
Redmile Group, LLC	15%		$24,052,456	17,816,634			$1.35	13D/A	20 Dec 2024	26 Dec 2024, 21:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.93%	0%	$12,648,957	12,872,946	0		$0.98	Q4 2025
30 Sep 2025	1.6%	0%	$16,219,912	12,872,946	0		$1.26	Q3 2025
30 Jun 2025	1.5%	0%	$14,417,700	12,872,946	0		$1.12	Q2 2025
31 Mar 2025	0.96%	0%	$10,170,915	12,872,946	0		$0.79	Q1 2025
31 Dec 2024	1.5%	-0.03%	$21,240,361	12,872,946	-296,111	-2.2%	$1.65	Q4 2024
30 Sep 2024	2.7%	0%	$46,091,700	13,169,057	0		$3.50	Q3 2024
30 Jun 2024	2.6%	0%	$43,194,507	13,169,057	0		$3.28	Q2 2024
31 Mar 2024	3.5%	0%	$96,660,878	13,169,057	0		$7.34	Q1 2024
31 Dec 2023	1.8%	+0.01%	$49,252,273	13,169,057	+44,630	+0.34%	$3.74	Q4 2023
30 Sep 2023	1.3%	0%	$27,823,785	13,124,427	0		$2.12	Q3 2023
30 Jun 2023	2.4%	+0.03%	$62,472,273	13,124,427	+167,205	+1.3%	$4.76	Q2 2023
31 Mar 2023	3.2%	0%	$73,856,165	12,957,222	0		$5.70	Q1 2023
31 Dec 2022	5.3%	0%	$130,738,370	12,957,222	0		$10.09	Q4 2022
30 Sep 2022	11%	0%	$290,371,000	12,957,222	0		$22.41	Q3 2022
30 Jun 2022	12%	0%	$321,080,000	12,957,222	0		$24.78	Q2 2022
31 Mar 2022	16%	0%	$502,351,000	12,957,222	0		$38.77	Q1 2022
31 Dec 2021	17%	0%	$758,127,000	12,957,222	0		$58.51	Q4 2021
30 Sep 2021	13%	0%	$767,975,000	12,957,222	0		$59.27	Q3 2021
30 Jun 2021	17%	0%	$1,124,557,000	12,957,222	0		$86.79	Q2 2021
31 Mar 2021	15%	+0.38%	$1,068,323,000	12,957,222	+327,485	+2.6%	$82.45	Q1 2021
31 Dec 2020	14%	0%	$1,148,422,000	12,629,737	0		$90.93	Q4 2020
30 Sep 2020	9.3%	0%	$504,811,000	12,629,737	0		$39.97	Q3 2020
30 Jun 2020	8%	+0.89%	$433,326,000	12,629,737	+1,412,928	+13%	$34.31	Q2 2020
31 Mar 2020	7%	0%	$249,125,000	11,216,809	0		$22.21	Q1 2020
31 Dec 2019	5.3%	0%	$219,513,000	11,216,809	0		$19.57	Q4 2019
30 Sep 2019	5.8%	+0.45%	$174,197,000	11,216,809	+857,143	+8.3%	$15.53	Q3 2019
30 Jun 2019	6%	0%	$210,301,000	10,359,666	0		$20.30	Q2 2019
31 Mar 2019	5.3%	0%	$182,019,000	10,359,666	0		$17.57	Q1 2019
31 Dec 2018	5.3%	0%	$132,915,000	10,359,666	0		$12.83	Q4 2018
30 Sep 2018	5.2%	+1.9%	$168,759,000	10,359,666	+3,703,704	+56%	$16.29	Q3 2018
30 Jun 2018	2.6%	0%	$75,479,000	6,655,962	0		$11.34	Q2 2018
31 Mar 2018	2.5%	+0.45%	$64,962,000	6,655,962	+1,190,476	+22%	$9.76	Q1 2018
31 Dec 2017	1.5%	+1.1%	$33,394,000	5,465,486	+4,046,428	+285%	$6.11	Q4 2017
30 Sep 2017	0.28%	0%	$5,619,000	1,419,058	0		$3.96	Q3 2017
30 Jun 2017	0.28%	0%	$4,598,000	1,419,058	0		$3.24	Q2 2017
31 Mar 2017	0.42%	0%	$6,457,000	1,419,058	0		$4.55	Q1 2017
31 Dec 2016	0.31%	-0%	$3,562,000	1,419,058	-6,100	-0.43%	$2.51	Q4 2016
30 Sep 2016	0.35%	-0.02%	$4,446,000	1,425,158	-77,022	-5.1%	$3.12	Q3 2016
30 Jun 2016	0.24%	+0%	$2,554,000	1,502,180	+15,200	+1%	$1.70	Q2 2016
31 Mar 2016	0.28%	-0.16%	$2,677,000	1,486,980	-884,021	-37%	$1.80	Q1 2016
31 Dec 2015	0.62%	+0.08%	$7,990,000	2,371,001	+296,165	+14%	$3.37	Q4 2015
30 Sep 2015	0.84%	+0.03%	$11,059,000	2,074,836	+67,390	+3.4%	$5.33	Q3 2015
30 Jun 2015	1.1%	+1.1%	$12,988,000	2,007,446	+2,007,446	NEW	$6.47	Q2 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.